Literature DB >> 1538791

N-acetyl oxyntomodulin30-37: pharmacokinetics and activity on gastric acid secretion.

C Carles-Bonnet1, C Jarrousse, H Niel, J Martinez, M Rolland, D Bataille.   

Abstract

Oxyntomodulin, an intestinal hormone which inhibits gastric acid secretion, is composed of glucagon and a C-terminal octapeptide. This octapeptide mimics the biological activity of the hormone. We have studied the activity of the N-acetyl octapeptide, partially protected against enzymatic degradation, on pentagastrin-, histamine- and milk meal-stimulated secretion in conscious rats and compared it to that of oxyntomodulin and its derivatives. The N-acetylated octapeptide had a 3-fold higher potency than the octapeptide on pentagastrin-stimulated secretion. On histamine-stimulated secretion, the differences between the acetylated and the free octapeptides were that the former displayed a dose-response curve parallel to that of oxyntomodulin and a 4-fold higher potency. The increase in potency appears to be related in part to a decrease in the metabolic clearance rate in vivo (6-fold) and, in vitro, to an increase in half-life (3-fold) when incubated with rat liver plasma membranes. Similarly to the free octapeptide, the acetylated form decreased acid secretion stimulated by a milk meal, when infused before the meal. Acetylation of the Lysine side chains resulted in a totally inactive molecule. The results indicate that acetylating the N-terminus of the octapeptide of oxyntomodulin increases the similarities with the natural hormone.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1538791     DOI: 10.1007/bf00175470

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  24 in total

1.  The effect of ulcerogenic drugs on gastric acidity in the rat with chronic fistula.

Authors:  D A BRODIE; R W MARSHALL; O M MORENO
Journal:  Gastroenterology       Date:  1962-12       Impact factor: 22.682

2.  Oxyntomodulin and its (19-37) and (30-37) fragments inhibit histamine-stimulated gastric acid secretion in the conscious rat.

Authors:  C Carles-Bonnet; C Jarrousse; H Niel; J Martinez; D Bataille
Journal:  Eur J Pharmacol       Date:  1991-10-15       Impact factor: 4.432

3.  Solid-phase peptide synthesis of human(Nle-27)-oxyntomodulin. Preliminary evaluation of its biological activities.

Authors:  M P Audousset-Puech; M Dufour; A Kervran; C Jarrousse; B Castro; D Bataille; J Martinez
Journal:  FEBS Lett       Date:  1986-05-05       Impact factor: 4.124

4.  [Demonstration of a specific receptor site for glucagon-37 (oxyntomodulin/bioactive enteroglucagon) in rat oxyntic glands].

Authors:  C Depigny; B Lupo; A Kervran; D Bataille
Journal:  C R Acad Sci III       Date:  1984

5.  Oxyntomodulin (glucagon-37) and its C-terminal octapeptide inhibit gastric acid secretion.

Authors:  C Jarrousse; M P Audousset-Puech; M Dubrasquet; H Niel; J Martinez; D Bataille
Journal:  FEBS Lett       Date:  1985-08-19       Impact factor: 4.124

6.  Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide.

Authors:  D Bataille; K Tatemoto; C Gespach; H Jörnvall; G Rosselin; V Mutt
Journal:  FEBS Lett       Date:  1982-09-06       Impact factor: 4.124

7.  Metabolic clearance rates of oxyntomodulin and glucagon in the rat: contribution of the kidney.

Authors:  A Kervran; M Dubrasquet; P Blache; J Martinez; D Bataille
Journal:  Regul Pept       Date:  1990-10-29

8.  Synthesis of the C-terminal octapeptide of pig oxyntomodulin. Lys-Arg-Asn-Lys-Asn-Asn-Ile-Ala: a potent inhibitor of pentagastrin-induced acid secretion.

Authors:  M P Audousset-Puech; C Jarrousse; M Dubrasquet; A Aumelas; B Castro; D Bataille; J Martinez
Journal:  J Med Chem       Date:  1985-10       Impact factor: 7.446

9.  Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat.

Authors:  A Kervran; P Blache; D Bataille
Journal:  Endocrinology       Date:  1987-08       Impact factor: 4.736

10.  Hamster preproglucagon contains the sequence of glucagon and two related peptides.

Authors:  G I Bell; R F Santerre; G T Mullenbach
Journal:  Nature       Date:  1983-04-21       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.